COVID-19 – Vaccine and Drug Development

Agilent Technologies Sales & Services GmbH & Co. KG

Notice

The provider currently does not offer this white paper for download. You can find additional white papers in our white paper directory.

COVID-19 – Vaccine and Drug Development

Streamline Your Development to Enable Confident Evaluation of Vaccine and Drug Candi-dates

Deeper Insights to Evaluate Vaccine Candidates Confidently:

Vaccine-originated immunity is one of the most effective protections against infectious diseases. Deeper insights are essential for identifying and developing safe pathogen and antigen candidates that will cause a long-lasting immune response.

Vaccine and Virology Application Handbook

Efficient methods to quantitatively characterize viral samples

Analytical Electrophoresis Applications Compendium

Find a comprehensive resource with proven methods for DNA, RNA, and protein si-ze and impurity analysis.